219 related articles for article (PubMed ID: 19065656)
1. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells.
Xu X; Zur Hausen A; Coy JF; Löchelt M
Int J Cancer; 2009 Mar; 124(6):1330-7. PubMed ID: 19065656
[TBL] [Abstract][Full Text] [Related]
2. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.
Langbein S; Zerilli M; Zur Hausen A; Staiger W; Rensch-Boschert K; Lukan N; Popa J; Ternullo MP; Steidler A; Weiss C; Grobholz R; Willeke F; Alken P; Stassi G; Schubert P; Coy JF
Br J Cancer; 2006 Feb; 94(4):578-85. PubMed ID: 16465194
[TBL] [Abstract][Full Text] [Related]
3. Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo.
Yuan W; Wu S; Guo J; Chen Z; Ge J; Yang P; Hu B; Chen Z
Cancer Biol Ther; 2010 May; 9(9):710-6. PubMed ID: 20200485
[TBL] [Abstract][Full Text] [Related]
4. Gene Suppression of Transketolase-Like Protein 1 (TKTL1) Sensitizes Glioma Cells to Hypoxia and Ionizing Radiation.
Heller S; Maurer GD; Wanka C; Hofmann U; Luger AL; Bruns I; Steinbach JP; Rieger J
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044385
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of transketolase protein TKTL1 is associated with occurrence and progression in nasopharyngeal carcinoma: a potential therapeutic target in nasopharyngeal carcinoma.
Zhang S; Yue JX; Yang JH; Cai PC; Kong WJ
Cancer Biol Ther; 2008 Apr; 7(4):517-22. PubMed ID: 18296915
[TBL] [Abstract][Full Text] [Related]
6. TKTL1 expression in human malign and benign cell lines.
Kämmerer U; Gires O; Pfetzer N; Wiegering A; Klement RJ; Otto C
BMC Cancer; 2015 Jun; 15():2. PubMed ID: 26187043
[TBL] [Abstract][Full Text] [Related]
7. Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.
Jayachandran A; Lo PH; Chueh AC; Prithviraj P; Molania R; Davalos-Salas M; Anaka M; Walkiewicz M; Cebon J; Behren A
BMC Cancer; 2016 Feb; 16():134. PubMed ID: 26907172
[TBL] [Abstract][Full Text] [Related]
8. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome.
Lange CA; Tisch-Rottensteiner J; Böhringer D; Martin G; Schwartzkopff J; Auw-Haedrich C
Ophthalmology; 2012 Sep; 119(9):1924-9. PubMed ID: 22658715
[TBL] [Abstract][Full Text] [Related]
9. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells.
Hu LH; Yang JH; Zhang DT; Zhang S; Wang L; Cai PC; Zheng JF; Huang JS
Anticancer Drugs; 2007 Apr; 18(4):427-33. PubMed ID: 17351395
[TBL] [Abstract][Full Text] [Related]
10. Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer.
Staiger WI; Coy JF; Grobholz R; Hofheinz RD; Lukan N; Post S; Schwarzbach MH; Willeke F
Oncol Rep; 2006 Oct; 16(4):657-61. PubMed ID: 16969476
[TBL] [Abstract][Full Text] [Related]
11. Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells.
Zhang S; Yang JH; Guo CK; Cai PC
Cancer Lett; 2007 Aug; 253(1):108-14. PubMed ID: 17321041
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia induces the expression of transketolase-like 1 in human colorectal cancer.
Bentz S; Cee A; Endlicher E; Wojtal KA; Naami A; Pesch T; Lang S; Schubert P; Fried M; Weber A; Coy JF; Goelder S; Knüchel R; Hausmann M; Rogler G
Digestion; 2013; 88(3):182-92. PubMed ID: 24193262
[TBL] [Abstract][Full Text] [Related]
13. Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer.
Földi M; Stickeler E; Bau L; Kretz O; Watermann D; Gitsch G; Kayser G; Zur Hausen A; Coy JF
Oncol Rep; 2007 Apr; 17(4):841-5. PubMed ID: 17342325
[TBL] [Abstract][Full Text] [Related]
14. Transketolase-like protein 1 confers resistance to serum withdrawal in vitro.
Hartmannsberger D; Mack B; Eggert C; Denzel S; Stepp H; Betz CS; Gires O
Cancer Lett; 2011 Jan; 300(1):20-9. PubMed ID: 20884117
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of TKTL1 additively complements cisplatin-induced cytotoxicity in nasopharyngeal carcinoma cells by regulating the levels of NADPH and ribose-5-phosphate.
Dong Y; Wang M
Biomed Pharmacother; 2017 Jan; 85():672-678. PubMed ID: 27916418
[TBL] [Abstract][Full Text] [Related]
16. Lack of transketolase-like (TKTL) 1 aggravates murine experimental colitis.
Bentz S; Pesch T; Wolfram L; de Vallière C; Leucht K; Fried M; Coy JF; Hausmann M; Rogler G
Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G598-607. PubMed ID: 21233279
[TBL] [Abstract][Full Text] [Related]
17. TKTL1 Knockdown Impairs Hypoxia-Induced Glucose-6-phosphate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase Overexpression.
Baptista I; Karakitsou E; Cazier JB; Günther UL; Marin S; Cascante M
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408935
[TBL] [Abstract][Full Text] [Related]
18. Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer.
Krockenberger M; Engel JB; Schmidt M; Kohrenhagen N; Häusler SF; Dombrowski Y; Kapp M; Dietl J; Honig A
Anticancer Res; 2010 May; 30(5):1653-9. PubMed ID: 20592357
[TBL] [Abstract][Full Text] [Related]
19. Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer.
Langbein S; Frederiks WM; zur Hausen A; Popa J; Lehmann J; Weiss C; Alken P; Coy JF
Int J Cancer; 2008 Jun; 122(11):2422-8. PubMed ID: 18302154
[TBL] [Abstract][Full Text] [Related]
20. Evidence for transketolase-like TKTL1 flux in CHO cells based on parallel labeling experiments and (13)C-metabolic flux analysis.
Ahn WS; Crown SB; Antoniewicz MR
Metab Eng; 2016 Sep; 37():72-78. PubMed ID: 27174718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
